BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31895162)

  • 1. Occupational kidney stones.
    Malieckal DA; Goldfarb DS
    Curr Opin Nephrol Hypertens; 2020 Mar; 29(2):232-236. PubMed ID: 31895162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The exposome for kidney stones.
    Goldfarb DS
    Urolithiasis; 2016 Feb; 44(1):3-7. PubMed ID: 26615595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimum nutrition for kidney stone disease.
    Heilberg IP; Goldfarb DS
    Adv Chronic Kidney Dis; 2013 Mar; 20(2):165-74. PubMed ID: 23439376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.
    Krieger NS; Asplin JR; Granja I; Ramos FM; Flotteron C; Chen L; Wu TT; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2019 Jul; 30(7):1163-1173. PubMed ID: 31101664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and prevention of kidney stones: an update.
    Frassetto L; Kohlstadt I
    Am Fam Physician; 2011 Dec; 84(11):1234-42. PubMed ID: 22150656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Fluid Management in Prevention of Kidney Stones: A PRISMA-Compliant Systematic Review and Dose-Response Meta-Analysis of Observational Studies.
    Xu C; Zhang C; Wang XL; Liu TZ; Zeng XT; Li S; Duan XW
    Medicine (Baltimore); 2015 Jul; 94(27):e1042. PubMed ID: 26166074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of the diet in urinary stone formation and prevalence].
    Szendrői A; Tordé Á; Vargha J; Bánfi G; Horváth A; Horváth C; Nyirády P
    Orv Hetil; 2017 Jun; 158(22):851-855. PubMed ID: 28561635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children.
    Sarica K; Erturhan S; Yurtseven C; Yagci F
    J Endourol; 2006 Nov; 20(11):875-9. PubMed ID: 17144854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate.
    Jendle-Bengten C; Tiselius HG
    Scand J Urol Nephrol; 2000 Feb; 34(1):36-41. PubMed ID: 10757268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine volume: stone risk factor and preventive measure.
    Borghi L; Meschi T; Schianchi T; Briganti A; Guerra A; Allegri F; Novarini A
    Nephron; 1999; 81 Suppl 1():31-7. PubMed ID: 9873212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifestyle recommendations to reduce the risk of kidney stones.
    Meschi T; Nouvenne A; Borghi L
    Urol Clin North Am; 2011 Aug; 38(3):313-20. PubMed ID: 21798393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis.
    Cheungpasitporn W; Rossetti S; Friend K; Erickson SB; Lieske JC
    J Nephrol; 2016 Apr; 29(2):211-219. PubMed ID: 26022722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of calcium in the prevention of kidney stones.
    Heller HJ
    J Am Coll Nutr; 1999 Oct; 18(5 Suppl):373S-378S. PubMed ID: 10511317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine volume and its effects on renal stone risk in astronauts.
    Whitson PA; Pietrzyk RA; Sams CF
    Aviat Space Environ Med; 2001 Apr; 72(4):368-72. PubMed ID: 11318017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.